Correlation Engine 2.0
Clear Search sequence regions


  • cases (3)
  • child (2)
  • diazepam (9)
  • humans (1)
  • midazolam (9)
  • pakistan (2)
  • patients (3)
  • seizures (6)
  • status epilepticus (6)
  • treatment failure (1)
  • weight (1)
  • Sizes of these terms reflect their relevance to your search.

    To compare the efficacy of intravenous midazolam and diazepam in the management of status epilepticus seizures in children. The comparative study was conducted in the paediatric neurological emergency unit of The Children's Hospital and the Institute of Child Health, Multan, Pakistan, from December 15, 2018, to May 14, 2019, and comprised paediatric patients of status epilepticus seizures which were divided into Diazepam and Midazolam groups. Data was analysed using Graph-Pad Prism 5. Of the 164 patients, 82(50%) were in each of the two groups. There was no significant difference between the groups in terms of weight, age, residence area of patients and mean duration of seizures (p>0.05). Status epilepticus seizures subsided after intravenous midazolam administration in 77(93.90%) cases, while success in the diazepam group 64(78.05%) (p<0.05). Mean time taken by midazolam to halt seizures was significantly shorter than diazepam (p<0.05) and less cases of treatment failure were observed with intravenous midazolam (p<0.05). Somnolence was observed after diazepam administration in 47(57.3%) cases (p=0.0001). Intravenous midazolam was found to be superior in efficacy than intravenous diazepam in controlling status epilepticus seizures.

    Citation

    Ayesha Kazmi, Ghulam Abbas, Asim Khurshid, Shahid Shah, Tauqeer Hussain Mallhi, Muhammad Hanif, Uzma Saleem, Abid Shah, Nabeel Riaz. A comparison of intravenous midazolam and diazepam in management of status epilepticus in children. JPMA. The Journal of the Pakistan Medical Association. 2021 Feb;71(2(B)):640-644

    Expand section icon Mesh Tags

    Expand section icon Substances


    PMID: 33941951

    View Full Text